.1 Cohort-specific impact scores
In the methods section of the main manuscript, we have derived the average contribution of each regulator j on the prediction of the expression level of a target gene i by
|a ji · e jd | |a ii · c id | + v =i |a vi · e vd | and we have determined the direct average copy number contribution of target gene i by
|a ii · c id | |a ii · c id | + v =i |a vi · e vd | under consideration of all D patients of a given cohort. These proportions were used to define a basic cohort-specific network flow matrix F = (f ji ) 1≤j,i≤N := p ji ·R 2 i by weighting the CCTN-derived explained variance R 2 i of target gene i in a given tumor cohort with the average proportions p ji of its corresponding direct predictors j.
Patient-specific absolute impact scores
To obtain patient-specific impact scores, we have computed the patient-specific proportion of each regulator j on the prediction of the expression level of target gene i by |a ii · c id | |a ii · c id | + v =i |a vi · e vd | for each individual patient d ∈ {1, . . . , D} in a given tumor cohort. In analogy to the cohort-specific impact scores derived on the basis of p ji and p ii followed by the application of our network propagation algorithm, the use of absolute values in the computations of p d ij and p d ii does not allow to distinguish between opposed effects of repression and activation by different predictors (gene copy number, regulator genes) of target gene i, but instead allow to account for the absolute contribution of both effects to identify those tumor-specific gene CNAs with the strongest total impact on survival signature genes.
In analogy to the definition of the basic cohort-specific impact matrix above, we used the proportions ing patient-specific basic network flow matrix F d is then utilized to compute a patient-specific network flow matrix F * d using the network propagation algorithm described in the methods section of the main manuscript.
Patient-specific relative impact scores
A slight modification of the computation of the patient-specific proportions allows to obtain patientspecific impact scores that account for repressor and activator interactions in CCTN. This is important to quantify the putative regulatory effects of each individual tumor-specific gene CNA on signature genes.
To realize this, we computed the patient-specific proportion of each regulator j on the prediction of the expression of target gene i by The resulting patient-specific basic network flow matrix F d is then utilized to compute the network flow matrix F * d as described in the methods section of the main manuscript with a slight modification of the convergence criterion. Since we now account for opposed effects of repressive and activating impacts propagated through CCTN, the impacts accumulated during the approximation of F * by taking into account paths of increasing lengths through CCTN are no longer guaranteed to increase monotonically until convergence is reached. Still, the absolute impact of a path of increasing length gets smaller, because one increases the path always by a multiplication with a proportion that is by definition in the interval (−1, 1), but the sign of the added impact can change. Therefore, we stop the approximation of F * d if the sum of the absolute differences of the column sums of the current and the previously approximated matrix is less than 1 · 10 -3 .
Text S2: Number of patient-specific gene CNAs alone does not allow to predict survival
We tested if a count statistic based on the number of patient-specific gene CNAs alone is sufficient to predict patient survival. Therefore, we determined the number of rare (frequency < 1%) and frequent gene CNAs (frequency >= 1%) for each patient in each of the six TCGA cohorts (AML, GBM, HNSC, LUAD, OV, SKCM). We did not find any significant correlation between the patient-specific number of gene CNAs (all gene CNAs, only frequent gene CNAs, or only rare gene CNAs) and survival for any cohort. In addition to the fact that such a frequency based approach would not allow to pinpoint specific genes, this also clearly indicated that the prediction of patient survival only based on the number of gene CNAs is not possible for the considered cohorts. This further motivated the application of our approach that allowed to identify patient-specific gene CNAs (out of the large set of patient-specific gene CNAs) that impact on survival.
Text S3: Single-gene tests widely fail to identify gene CNAs that impact on survival
We have shown that our approach allows to pinpoint rare and frequent gene CNAs that act on survival signature genes (Fig. 4) and that our approach can distinguish between short and long patient survival (Fig. S14b) . Next, we investigated if a basic statistical analysis based on single-gene tests would allow to identify differences in survival between patients with and without a specific gene CNA. Such a basic approach has at least three major limitations in comparison to our approach: (i) each specific gene CNA can only be considered in isolation independent of the other patient-specific gene CNAs, (ii) it will be almost impossible to analyze the impact of rare gene CNAs on survival due to the limited number of patients that have such a mutation, and (iii) potential regulatory links through which gene CNAs may act on survival remain hidden. However, we determined for each of the six TCGA cohorts (AML, GBM, HNSC, LUAD, OV, SKCM) all genes that had at least two gene CNAs within a cohort. We further treated deletions and amplifications separately and compared the survival of patients with and without a specific gene CNA using a t-test. We corrected for multiple testing by computing q-values and visualized the q-values with their corresponding gene CNA frequencies (Fig. S20) . Only in the case of AML some frequent gene CNAs associated with differences in patient survival were identified (q-value < 0.01).
Further, as expected, this basic approach did not allow to identify any significant rare gene CNA that acted on survival. Thus, this further motivated the application of our approach to pinpoint rare and frequent gene CNAs that act on patient survival.
Text S4: Impact scoring only utilizing directly acting gene CNAs classifies a reduced number of patients with less discriminative power
In addition, we compared our CCTN-based impact quantification approach, which considers all patientspecific gene CNAs that directly or indirectly act on survival signature genes, to a basic CCTN-based version. This basic version only considers CNAs of regulator genes in the direct network neighborhood of survival signature genes to distinguish between short and long-lived patients. This is computationally realized by only utilizing the basic network flow matrix F d (direct impacts between gene pairs) instead of the final network flow matrix F * d (direct and indirect impacts between gene pairs) obtained via network propagation. Details to the computation of both matrices are given in the Methods section of the main manuscript and in Text S1. Thus, except for the quantification of indirect impacts, both impact quantification approaches were identical. This enabled a fair comparison to quantify the importance and additional contribution of gene CNAs that indirectly act on survival signature genes via regulatory paths defined by CCTN. We compared both impact scoring approaches on five independent test cohorts and found that our CCTN-based impact quantification approach that integrates directly and indirectly acting gene CNAs significantly improved the number of classifiable patients and the separation between short and long-lived patients (Fig. 8) . Details are given in the Results section of the main manuscript.
Text S5: A strong enrichment of non-significant p-values is expected from the mathematical theory behind the significance test for lasso
The highly left-skewed p-value distributions (strong enrichment of non-significant p-values close to one)
in Fig. S24a are explained by the mathematical theory behind the significance test for lasso (Lockhart et al. (2014) ). The underlying covariance test statistic asymptotically follows an exponential distribution Exp(1) with scale parameter one. Further, the comparison of the test statistic along the lasso path to this exponential distribution is increasingly conservative. In more detail, consider a set of N predictors of which the first predictors {1, . . . , n} are the truly active ones, whereas the remaining predictors {n + 1, . . . , N } are the truly non-active ones. It was shown in Lockhart et al. (2014) that the covariance test statistic of each truly active predictor follows an Exp(1), whereas the test statistic of each truly non-active predictor i ∈ {n + 1, . . . , N } follows an Exp(s) with scale parameter s := 1/i. Because truly active and non-active predictors are generally not known, the comparison of the covariance test statistic along the lasso path to is done to the Exp(1), which is increasingly conservative. This means that as the number of active predictors in the model increases, it is less and less likely to integrate a predictor based on a false rejection of the null hypothesis that all truly active predictors are already included in the model. Thus, for a fixed value of the covariance test statistic, the p-value obtained under Exp(1) is greater than under an exponential distribution with smaller scaling parameter (Fig. S24c) . This leads to the observation of the highly left-skewed p-value distribution (Fig. S24d) , which favors the parsimony of the model (Lockhart et al. (2014) ). Thus, as expected for lasso-based network inference, only very few predictor genes are required for the prediction of the expression levels of specific response genes, whereas the majority of predictors is shrunken to zero. CLCGP. Both network models reach nearly the same prediction quality. In summary, tumor type-specific network models tend to reach moderately better predictions for their specific tumor domain than CCTN (a and b), but the generalization of these tumor type-specific network models to other tumor types is weaker than for CCTN (c) or in the range of CCTN (d). Based on these results, BRCA and LUSC were excluded from the subsequent analysis and only the cohorts with more than 100 patients (AML, GBM, HNSC, LUAD, OV, and SKCM) were kept. TCGA_AML  TCGA_BRCA  TCGA_GBM  TCGA_HNSC  TCGA_LUAD  TCGA_LUSC  TCGA_OV : Survival prediction on held out patient samples comparing our random forest approach (RF) against random survival forest without (RSF) and with censoring (RSFC). The RF-approach directly predicted survival for each patient, whereas RSF and RSFC predict a mortality value for each patient. RF and RSF were trained on each TCGA cohort on the same set of patients that were already dead. RSFC additionally utilized all patients that were alive (censoring). Survival prediction quality was evaluated by correlating the predicted survival or mortality with real patient survival. Note that one would expect negative correlations between mortality and real survival for a predictive RSF and RSFC on held out samples, because a high mortality indicates a low patient survival. Significant correlations are represented by '*' (p-value < 0.1), '**' (p-value < 0.05) and '***' (p-value < 0.01). Overall, RF tended to reach the best prediction of patient survival from gene expression data except for AML. Figure S11: Evaluation of the survival prediction quality of the TCGA GBM Random Forest (RF) for independent GBM patients from Rembrandt (Madhavan et al. (2009) ). Data were filtered and pre-processed as described in Seifert et al. (2014) . Gene expression data and survival information of 36 GBM patients were used to test the RF obtained from the TCGA GBM cohort. The obtained significant correlation between RF-predicted and real patient survival clearly indicates that the RF has learned GBM relevant survival signature genes. Figure S12: Average correlation profiles between RF-predicted and real patient survival for successively increasing numbers of permuted top-ranking survival predictors for 1,000 permutation runs. Individual TCGA cohort-specific correlation profiles dye out towards zero enabling to select the most relevant genes associated with patient survival.
Figure S8: Summary of LINCS-based validation of CCTN impact values

Figure S10: Comparison of RF to RSF without and with censoring
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We considered a stringent (all predictor genes above a correlation cutoff of 0.1) and a less stringent correlation cutoff (all predictor genes above a correlation cutoff of 0.05) to derive TCGA cohort-specific survival signature genes.
Results for survival signature genes obtained based on the stringent cutoff are described in the main manuscript.
Similar results obtained for the less stringent cutoff are additionally shown in the appendix ( Fig. S13 and Fig. S17 ).
See Tab. S6 for TCGA cohort-specific survival signature genes. were filtered and pre-processed in Seifert et al. (2014) . We first demonstrated that the survival of Rembrandt GBM patients was predictable using the Random Forest (RF) learned from gene expression profiles and survival information of GBM patients from the TCGA cohort (Fig. S11) . We then determined all GBM survival signature genes from the TCGA GBM RF that were above a correlation cutoff of 0.05 (Fig. S12 , Tab. S6). We now computed for each of the 36 Rembrandt GBM patients a patient-specific impact matrix utilizing our network propagation algorithm with respect to initial computations based on CCTN using the patient-specific gene expression and gene copy number were also always gene CNAs in each cohort that had high impact on the survival signature genes. We therefore ranked the gene CNAs in each cohort from low to high impacts and computed the cumulative sum of impacts.
We then plotted the cumulative impact against the number of involved CNA genes enabling to distinguish between low impact genes (cumulative impact close to zero) and high impact genes (cumulative impact clearly greater than zero). For each TCGA cohort, we selected all genes above a cumulative impact cutoff of one (black dashed line) as corresponding high survival impact genes. The resulting genes are considered in the analysis that is part of the main manuscript. See Tab. S7 for individual impact scores of TCGA cohort-specific genes affected by CNAs. We further confirmed that the selected survival impact genes above the black dashed line had impact values that were highly significant in comparison to corresponding gene-specific impact scores obtained for each tumor cohort under consideration of ten random networks of the same complexity as CCTN (degree-preserving network permutations).
The obtained q-values for all cohort-specific selected CNA-impact genes were less than 0.006 (ranged from 0.0048 for GBM to 0.0058 for HNSC). See methods in the main manuscript for details. SUSD1   IL18   PRTFDC1   DNASE2B   CLEC4M   COG2  DNAJC2  JTB  THAP10  LYST   SGK2   IARS2   SOSTDC1   TRA2B  SLC45A2  LYPD3  TRIM63  WDR91  IKBIP  LYPLA2  YPEL1  SNAPC1  POLR3G  COG2  DNAJC2  METAP1 (genes with a correlation above 0.05 in Fig. S12 ). Generally, the overall cohort-specific trends are highly similar for the different cutoffs. Fig. S15 ). The resulting cohort-specific high-impact gene CNAs were further separated into rarely (CNA frequency< 1%) and frequently (CNA frequency >= 1%) mutated genes.
Figure S16: Genomic locations of rare and frequent survival-impact genes
The chromosomal distances of rare and frequent gene CNAs from known essential genes, fragile sites, oncogenes, tumor suppressor genes, and known frequently observed CNV sites in human germ cells were computed and visualized by cohort-specific boxplots. See Tab. S8-10 for known genomic features. The distance distributions are highly tumor-type-specific. Significant differences in distances to known genomic features between rarely and frequently gene CNAs are represented by '*' (p-value < 0.05) and '**' (p-value < 0.01) based on Wilcoxon tests. Figure S24 : a, P-value distributions of active CCTN predictors that were selected based on lasso for ten different CCTN instances. All p-value distributions show a strong enrichment of non-significant p-values close to one and a smaller peak for highly significant p-values with values close to zero. P-values in between these two extremes tend to be uniformly distributed. As one would expect for lasso-based network inference, only very few predictor genes were selected as predictors for the prediction of the expression levels of specific response genes (small p-values close to zero), whereas the majority of predictors is not relevant (p-values clearly greater than zero or close to one). Considering CCTN in our analysis, we only focused on those predictors that had p-values < 5 · 10 -5
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(standard numerical precision limit of the R package covTest defining the smallest p-value that is provided by this package before p-values are rounded to zero by covTest) in all ten CCTN instances. b, Quantile-quantile plot comparing the pooled p-value distribution of the ten CCTN instances against a uniform distribution. The enrichment of model p-values close to one is explained by the theory behind the covariance test statistic by Lockhart et al. (2014) . Comparisons of the test statistic against an exponential distribution Exp(1) with scale parameter one along the lasso path are increasingly conservative leading to an enrichment of greater p-values as illustrated in c and d. c, P-value functions for the covariance test statistic by Lockhart et al. (2014) . The underlying covariance test statistic used to determine the p-values asymptotically follows an exponential distribution Exp(1) with scale parameter one (red). In more detail, consider a set of N predictors of which the first predictors {1, . . . , n} are the truly active ones, whereas the remaining predictors {n + 1, . . . , N } are the truly non-active ones. It was shown in Lockhart et al. (2014)Lasso-regression in combination with the significance test is expected to account for the collinearity of response gene-specific predictors by selecting only those predictors that best explain the expression of the response gene.
For CCTN this is done by lasso-based shrinkage of individual predictor parameters toward zero to remove irrelevant predictors and by an additional selection of predictors with highly significant p-values. The histogram clearly shows that the vast majority of variance inflation factors is close to one. Only 0.16% of all variance inflation factors were greater than ten. Thus, as one would expect for lasso approach, CCTN accounts for collinearity of predictors. and cohort-specific impact matrices were computed by our network propagation algorithm with respect to CCTN.
See methods in the main manuscript and Text S1 for details. The resulting impact matrices enable to quantify the direct and indirect impact of each specific gene on the expression of an another specific gene. Since these computations are extremely time and resource consuming, we randomly selected 100 tumor patients from each TCGA cohort for the computation of patient-specific impact scores. a -f, Correlations between all patient-specific impact values and corresponding cohort-specific impact values focusing on cohort-specific survival signature genes. g -l,
Correlations between all patient-specific impact values and corresponding cohort-specific impact values considering all 15,942 × 15,942 impact values for genes included in CCTN.
